The Commission on Narcotic Drugs is one of the functional commissions of the United Nations Economic and Social Council (ECOSOC) and is the central drug policy-making body within the United Nations system. The Commission has important functions under the drug control treaties in force today; most notably, it can amend the Schedules of controlled substances under the Single Convention on Narcotic Drugs and the Convention on Psychotropic Substances.
The Commission on Narcotic Drugs was established by the ECOSOC in 1946, with Canadian Charles Henry Ludovic Sharman as its first chair. Its predecessor, the Advisory Committee on the Traffic in Opium and Other Dangerous Drugs, was established by the first Assembly of the League of Nations on December 15, 1920. The Advisory Committee held its first meeting from May 2 to May 5, 1921, and continued its activities until 1940.
The drug control treaties divide power between the Commission and the International Narcotics Control Board. The Commission has power to influence drug control policy by advising other bodies and deciding how various substances will be controlled. However, enforcement power is reserved to the Board.
Under Article 8 of the Single Convention on Narcotic Drugs, the Commission's powers are to:
Under Article 17 of the Convention on Psychotropic Substances, the Commission has power to amend the Schedules by a two-thirds vote and "may consider all matters pertaining to the aims of this Convention and to the implementation of its provisions, and may make recommendations relating thereto."
The United Nations General Assembly has power to modify the Commission's decisions, with the exception of scheduling decisions.
The drug control treaties divide drugs into four Schedules with varying levels of control. Article 3 of the Single Convention and Article 2 of the Convention on Psychotropic Substances set out the scheduling procedure, giving the Commission the power to decide which Schedule a drug or other substance shall be placed into. However, the Economic and Social Council has power to alter or reverse the Commission's scheduling decisions. In addition, each Schedule has certain findings that the World Health Organization must make with regard to a drug or substance before it be placed in that Schedule. The relationship between the WHO and the Commission is described as follows by the Commentary on the Single Convention on Narcotic Drugs: